With country participation from Luxembourg, United Kingdom, Germany and China, as well as state presence from Maharashtra, Gujarat, Andhra Pradesh, Telangana, Punjab, Haryana, Tamil Nadu, Delhi and Uttarakand, PharmaLytica is well on its way to becoming a truly pan-India congregation that reaches out to all major Industry sectors and Pharma Hubs.
This year’s edition witnessed special pavilions dedicated to Pharma Machinery & Packaging; Lab Analytical & Cleanroom and API’s & Excipients Pavilion.
Among other notable showcases, India’s top academic institution IIT Powai, Mumbai exhibited its State of Art Analytical Lab - the Sophisticated Analytical Instrument Facility (SAIF). The facility was originally established at the Indian Institute of Technology, Bombay, in the year 1976, with the support of the Department of Science & Technology, Government of India, New Delhi. Besides, a special 3 hour workshop on the ‘Role & Commitment of GMP in Pharma’ by SGS Academy has been organised on Day 3 that would be invaluable for pharma corporates attending the show.
As the much respected generics market in India has reached its potential, the show provides an ideal platform for pharma professionals to also ramp up the ancillary section of the industry to keep abreast with innovations in the growing businesses of the global pharma sector: Apart from Pharma ingredients, increasingly, companies are looking at sub sectors such as Analytical & Bio Tech, Lab equipments & Lab Chemicals, Pharma Machinery and Packaging with significant success. At PharmaLytica, every participant gets an opportunity to pick up on the latest industry trends and innovations as well as network with the Pharma business community offering each other a value proposition..”
“Given our growing and unparalleled offering in the Pharma domain, we are pleased to move PharmaLytica to Mumbai to add immense value to the strong Western market in addition to the Southern one. ” he further added.
India enjoys an important position in the global pharmaceuticals sector and the largest provider of generic drugs globally. The country’s pharmaceutical industry is expected to expand at a CAGR of 22.4 per cent over 2015–20 to reach US$ 55 billion. India’s pharmaceutical exports stood at US$ 17.27 billion in FY18 and have reached US$ 15.52 billion in FY19 (up to January 2019).